Clinical Trials · NCT07850063
ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease
- Phase
- Phase 3
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Boehringer Ingelheim
- Enrollment
- 600
- Start date
- Oct 2026
- Locations
- 11 sites, 5 countries
- Primary endpoint
- Composite average Z-score (dimensionless) at Week 76 of cardiac structural and functional parameters